Evercore ISI Group Downgrades Seagen to In-Line, Raises Price Target to $229
Evercore ISI Group analyst Joshua Schimmer downgrades Seagen (NASDAQ:SGEN) from Outperform to In-Line and raises the price target from $175 to $229.
Craig-Hallum Downgrades Edgio to Hold, Lowers Price Target to $1
Craig-Hallum analyst Jeff Van Rhee downgrades Edgio (NASDAQ:EGIO) from Buy to Hold and lowers the price target from $2.5 to $1.
Wells Fargo Downgrades Signature Bank
Wells Fargo analyst Steven Chercover downgrades Signature Bank (NASDAQ:SBNY)
Odeon Capital Downgrades KeyCorp to Hold
Odeon Capital analyst Dick Bove downgrades KeyCorp (NYSE:KEY) from Buy to Hold.
Credit Suisse Downgrades Diversey Hldgs to Neutral, Lowers Price Target to $8.4
Credit Suisse analyst John Roberts downgrades Diversey Hldgs (NASDAQ:DSEY) from Outperform to Neutral and lowers the price target from $9 to $8.4.
Citigroup Downgrades Petco Health and Wellness to Neutral, Announces $11 Price Target
Citigroup analyst Steven Zaccone downgrades Petco Health and Wellness (NASDAQ:WOOF) from Buy to Neutral and announces $11 price target.
Bernstein Downgrades Lam Research to Market Perform
Bernstein analyst Stacy Rasgon downgrades Lam Research (NASDAQ:LRCX) from Outperform to Market Perform.
UBS Downgrades United Natural Foods to Neutral, Lowers Price Target to $32
UBS analyst Mark Carden downgrades United Natural Foods (NYSE:UNFI) from Buy to Neutral and lowers the price target from $48 to $32.
Raymond James Downgrades First Republic Bank to Market Perform
Raymond James analyst David Long downgrades First Republic Bank (NYSE:FRC) from Strong Buy to Market Perform.
Keefe, Bruyette & Woods Downgrades Hercules Capital to Underperform, Lowers Price Target to $10.5
Keefe, Bruyette & Woods analyst Ryan Lynch downgrades Hercules Capital (NYSE:HTGC) from Market Perform to Underperform and lowers the price target from $14.5 to $10.5.